These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer. Truong H, Breen K, Nandakumar S, Sjoberg DD, Kemel Y, Mehta N, Lenis AT, Reisz PA, Carruthers J, Benfante N, Joseph V, Khurram A, Gopalan A, Fine SW, Reuter VE, Vickers AJ, Birsoy O, Liu Y, Walsh M, Latham A, Mandelker D, Stadler ZK, Pietzak E, Ehdaie B, Touijer KA, Laudone VP, Slovin SF, Autio KA, Danila DC, Rathkopf DE, Eastham JA, Chen Y, Morris MJ, Offit K, Solit DB, Scher HI, Abida W, Robson ME, Carlo MI. Eur Urol; 2023 Jan; 83(1):29-38. PubMed ID: 36115772 [Abstract] [Full Text] [Related]
3. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines. Nicolosi P, Ledet E, Yang S, Michalski S, Freschi B, O'Leary E, Esplin ED, Nussbaum RL, Sartor O. JAMA Oncol; 2019 Apr 01; 5(4):523-528. PubMed ID: 30730552 [Abstract] [Full Text] [Related]
5. Germline pathogenic variants in unselected Korean men with prostate cancer. So MK, Ahn HK, Huh J, Kim KH. Investig Clin Urol; 2022 May 01; 63(3):294-300. PubMed ID: 35534218 [Abstract] [Full Text] [Related]
11. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer. Ledet EM, Burgess EF, Sokolova AO, Jaeger EB, Hatton W, Moses M, Miller P, Cotogno P, Layton J, Barata P, Lewis BE, Nakazawa M, Zhu J, Dellinger B, Elrefai S, Nafissi NN, Egan JB, Shore N, McKay RR, Bryce AH, Cheng HH, Antonarakis ES, Sartor O. Prostate; 2021 May 01; 81(7):433-439. PubMed ID: 33792945 [Abstract] [Full Text] [Related]
12. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer. Isaacsson Velho P, Silberstein JL, Markowski MC, Luo J, Lotan TL, Isaacs WB, Antonarakis ES. Prostate; 2018 Apr 01; 78(5):401-407. PubMed ID: 29368341 [Abstract] [Full Text] [Related]
15. Bringing Prostate Cancer Germline Genetics into Clinical Practice. Das S, Salami SS, Spratt DE, Kaffenberger SD, Jacobs MF, Morgan TM. J Urol; 2019 Aug 01; 202(2):223-230. PubMed ID: 30730411 [Abstract] [Full Text] [Related]
16. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer. Darst BF, Dadaev T, Saunders E, Sheng X, Wan P, Pooler L, Xia LY, Chanock S, Berndt SI, Gapstur SM, Stevens V, Albanes D, Weinstein SJ, Gnanapragasam V, Giles GG, Nguyen-Dumont T, Milne RL, Pomerantz M, Schmidt JA, Mucci L, Catalona WJ, Hetrick KN, Doheny KF, MacInnis RJ, Southey MC, Eeles RA, Wiklund F, Kote-Jarai Z, Conti DV, Haiman CA. J Natl Cancer Inst; 2021 May 04; 113(5):616-625. PubMed ID: 32853339 [Abstract] [Full Text] [Related]
17. Novel Germline Mutations in a Cohort of Men with Familial Prostate Cancer. Mondschein R, Bolton D, Clouston D, Dowty J, Kavanagh L, Murphy D, Scott P, Taylor RA, Thorne H. Cancers (Basel); 2022 Jul 26; 14(15):. PubMed ID: 35892882 [Abstract] [Full Text] [Related]
18. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer. Lee DJ, Hausler R, Le AN, Kelly G, Powers J, Ding J, Feld E, Desai H, Morrison C, Doucette A, Gabriel P, Genetics Center R, Judy RL, Weaver J, Kember R, Damrauer SM, Rader DJ, Domchek SM, Narayan V, Schwartz LE, Maxwell KN. Eur Urol; 2022 Jun 26; 81(6):559-567. PubMed ID: 34711450 [Abstract] [Full Text] [Related]
19. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, Hallberg E, Moore R, Thomas A, Lilyquist J, Feng B, McFarland R, Pesaran T, Huether R, LaDuca H, Chao EC, Goldgar DE, Dolinsky JS. JAMA Oncol; 2017 Sep 01; 3(9):1190-1196. PubMed ID: 28418444 [Abstract] [Full Text] [Related]